Mode
Text Size
Log in / Sign up

Pulsed field ablation reduces procedure time compared to very high-power short-duration ablation in atrial fibrillationPulsed field ablation speeds up heart surgery for atrial fibrillation

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that PFA significantly reduces procedure time compared to vHPSD without affecting recurrence or complication rates.

This meta-analysis synthesized data from 11 observational studies to compare pulsed field ablation (PFA) and very high-power short-duration ablation (vHPSD) in patients undergoing catheter ablation for atrial fibrillation. The primary outcome, recurrence rate of atrial fibrillation, showed no significant difference between the PFA and vHPSD groups (RR = 0.99; 95%CI: 0.91 to 1.07; P = 0.722).

Secondary outcomes also showed no statistically significant differences between the two techniques regarding the rate of pulmonary vein isolation (RR = 1.00; 95%CI: 1.00 to 1.00; P = 1.000) or the total incidence of surgery-related complications (RR = 0.89; 95%CI: 0.58 to 1.35; P = 0.5353). However, a significant difference was observed in procedure time, which was significantly shorter for the PFA group (MD = -31.64; 95%CI: -40.22 to -23.06).

The authors note that there are currently limited high-quality studies regarding the clinical efficacy and safety of these two specific ablation methods. Clinical application should be interpreted with caution due to the reliance on observational data and the limited volume of high-quality evidence.

How this fits prior evidence

This meta-analysis addresses a gap in comparing modern catheter ablation techniques for atrial fibrillation. While prior coverage noted that adding left atrial appendage electrical isolation to pulmonary vein isolation reduces recurrent atrial arrhythmia, this study focuses on the technical comparison between PFA and vHPSD. It confirms that while both methods may achieve similar outcomes regarding recurrence and complications, PFA offers a significant reduction in procedure time.

Living with an irregular heartbeat, known as atrial fibrillation, can be exhausting. Doctors often use a procedure called catheter ablation to treat it. Recent data compared two different ways of performing this procedure: the standard high-power short-duration method and a newer technique called pulsed field ablation (PFA).

Researchers looked at 1,476 patients across 11 studies. They found that while both methods were equally effective at stopping the irregular heartbeats and isolating the pulmonary veins, the pulsed field ablation method was significantly faster. Specifically, it reduced the time spent in the procedure by about 32 minutes on average.

Safety data showed no significant difference in complications between the two methods. However, because this analysis relied on observational studies, the evidence is still limited. While the faster timing is a clear benefit for patients and staff, more high-quality research is needed to fully confirm the long-term safety and success of pulsed field ablation.

What this means for you:
Pulsed field ablation takes less time than standard methods but shows similar success rates for heart conditions.

Common questions

Is the new pulsed field ablation method safer than traditional techniques?

The study found no significant difference in the total number of surgery-related complications between pulsed field ablation and high-power short-duration ablation. Both methods appeared to have similar safety profiles based on the 1,476 patients included in the analysis.

Is pulsed field ablation more effective at treating heart issues?

The study found no significant difference in the recurrence rate of atrial fibrillation or the rate of pulmonary vein isolation between the two methods. Both techniques performed similarly in successfully treating the underlying heart condition.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BackgroundPulsed field ablation (PFA) and very high power short duration ablation (vHPSD) are new techniques for catheter ablation of atrial fibrillation that have been rapidly developed in recent years. However, there are still limited high-quality studies on the clinical efficacy and safety of the two methods in the treatment of atrial fibrillation.MethodsWe searched PubMed, Embase, Wanfang, CNKI and other Chinese and English databases to collect relevant studies on the efficacy and safety of PFA vs. vHPSD in the treatment of AF published up to May 11, 2026. Two researchers independently completed literature screening and data extraction. We used the Newcastle-Ottawa Scale (NOS) and ROBINS-I tool to evaluate the study quality and risk of bias, respectively. Pooled effect sizes were calculated using random-effects models, and meta-regression and sensitivity analyses were conducted to explore heterogeneity and publication bias.ResultsA total of 11 observational studies involving 1,476 patients were included. Meta-analysis showed that there was no significant difference in the recurrence rate of atrial fibrillation between the PFA group and the vHPSD group during the follow-up period (RR = 0.99, 95%CI: 0.91 to 1.07, P = 0.722). There was no significant difference in the rate of pulmonary vein isolation between the two groups (RR = 1.00, 95%CI: 1.00 to 1.00, P = 1.000). In terms of safety outcomes, there was no significant difference in the total incidence of surgery-related complications between the two groups (RR = 0.89, 95%CI: 0.58 to 1.35, P = 0.5353). In the continuous outcomes, there were significant differences in procedure time (MD = −31.64, 95%CI: −40.22 to −23.06, P 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.